Disc Medicine, Inc. - Common Stock (NQ:IRON)

68.46 -0.39 (-0.57%)

Streaming Delayed Price Updated: 12:42 PM EDT, Apr 27, 2026 Add to My Watchlist

Price and Volume

Volume	62,668
Open	68.32
Bid (Size)	68.27 (200)
Ask (Size)	68.55 (100)
Prev. Close	68.85
Today's Range	68.31 - 69.82
52wk Range	40.00 - 99.50
Shares Outstanding	22,877,552
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

April 25, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

April 21, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-13.4%	-13.4%
1 Month	+13.9%	+13.9%
3 Month	-11.7%	-11.7%
6 Month	-23.6%	-23.6%
1 Year	+48.3%	+48.3%

More News

Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge ↗

April 21, 2026

Via The Motley Fool

Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting

April 21, 2026

From Disc Medicine Inc

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

March 27, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

March 26, 2026

From Disc Medicine Inc

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON

March 19, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm

March 18, 2026

From Schall Law

Via GlobeNewswire

IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm

March 14, 2026

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

March 03, 2026

From Pomerantz LLP

Via GlobeNewswire

Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection ↗

March 01, 2026

Via The Motley Fool

Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 26, 2026

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗

February 25, 2026

Via The Motley Fool

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗

February 25, 2026

Via The Motley Fool

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges ↗

February 25, 2026

Via The Motley Fool

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗

February 25, 2026

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON

February 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Disc Medicine to Participate in Upcoming Investor Conferences

February 24, 2026

From Disc Medicine Inc

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON

February 17, 2026

From Pomerantz LLP

Via GlobeNewswire

Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns ↗

February 13, 2026

Via Stocktwits

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP

February 13, 2026

From Disc Medicine Inc

Via GlobeNewswire

Frequently Asked Questions

Is Disc Medicine, Inc. - Common Stock publicly traded?

Yes, Disc Medicine, Inc. - Common Stock is publicly traded.

What exchange does Disc Medicine, Inc. - Common Stock trade on?

Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Disc Medicine, Inc. - Common Stock?

The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market

What is the current price of Disc Medicine, Inc. - Common Stock?

The current price of Disc Medicine, Inc. - Common Stock is 68.46

When was Disc Medicine, Inc. - Common Stock last traded?

The last trade of Disc Medicine, Inc. - Common Stock was at 04/27/26 12:42 PM ET

What is the market capitalization of Disc Medicine, Inc. - Common Stock?

The market capitalization of Disc Medicine, Inc. - Common Stock is 1.57B

How many shares of Disc Medicine, Inc. - Common Stock are outstanding?

Disc Medicine, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.